רÀûÃû³Æ£º·ÖÎöµ°°×µÄ¿¹Ô±íλµÄ·½·¨
¼¼ÊõÁìÓò£º
±¾·¢Ã÷Éæ¼°Ò»ÖÖ·ÖÎöµ°°×µÄ¿¹Ô±íλµÄ·½·¨¡£
¼¼Êõ±³¾°
ËÞÖ÷µÄ¿¹Ìå·´Ó¦ÔÚµÖ¿¹²¡ÔÌå¸ÐȾµÄ¹ý³ÌÖÐÆð×ÅÖØÒª×÷Ó㬶øÌåÄڵĶà¿Ë¡¿¹ Ìå·´Ó¦ÊÇÓÉÕë¶Ô²»Í¬¿¹Ô»òͬһ¿¹ÔµÄ²»Í¬¿¹Ô±íλµÄµ¥¿Ë¡¿¹Ìå×é³ÉµÄ¡£ÉîÈëµÄÀí½â Õâ¸ö¸´ÔӵĹý³ÌÄܹ»ÎªÑо¿¼²²¡µÄ·¢²¡»úÖÆÌṩ¹Ø¼üµÄÐÅÏ¢£¬»¹Äܹ»Îª¸ßЧÒßÃçµÄÑз¢ ºÍ¼²²¡ÖÎÁÆÌá¹©ÖØÒªµÄÀíÂÛ»ù´¡¡£
ÔÚ¿¹Ô±íλµÄÖî¶àÑо¿·½·¨ÖУ¬ÐËÆðÓÚ1990ÄêµÄÊɾúÌåչʾëĿ⼼Êõ (Scott, J.K.and G.P.Smith, Searching for peptide ligands with an epitope library.Science,1990.249 (4967) p.386-90.),¼´ÓÃËæ»úºÏ³ÉµÄ¶ÌëÄÎÄ¿â(Ò»°ã6_12¸ö°±»ùËᣬ¿âÈÝÁ¿´ï IOll-IO12)ºÍÊɾúÌåչʾϵͳ½øÐÐɸѡµÄ·½·¨£¬ÒÔÆä¿ì½Ý¡¢×¼È·¡¢²»Êܰ±»ùËáλµãÏÞÖÆµÄ ÓÅµã¶øÖð½¥³ÉΪĿǰӦÓÃ×î¹ã¡¢·¢Õ¹×î¿ìµÄ¿¹Ô±íλɸѡƽ̨֮һ¡£È»¶ø£¬ÊɾúÌåչʾ ëĿ⼼ÊõÒ²´æÔںܴóµÄ¾ÖÏÞÐÔ(1)¶ÌëÄÎÄ¿â¿ÉÒÔ²úÉúµÄ¾ø´ó²¿·ÖÊÇÏßÐÔ±í룬²»ÄÜºÜ ºÃµØÄ£ÄâÕ¼¿¹Ô±íλ80%ÒÔÉϵĹ¹ÏóÐͱíλ£»(2)ÊɾúÌåµÄÒ¿ǵ°°×ËùÄÜÈÝÄɵÄÍâÔ´·Ö ×ÓС¡¢½á¹¹¼òµ¥£¬¶ÔÍâÔ´µ°°×ȱ·¦ÐÞÊΣ¬¸ÃϵͳÖкܶàϸ°û¶¾ÐÔ·Ö×ÓºÍÕæºËÉúÎïµ°°×ÄÑ ÒÔ±í´ïºÍչʾ£»( ÊɾúÌå¸öÌå¹ýС£¬¶à²ÉÓÃÇ׺ϲãÎöÖù»òÇ׺Ͼ۱½ÒÒÏ©°å½øÐÐɸѡ£¬ ɸѡЧÂʵͣ»(4)ÿÂÖɸѡºó£¬ÊɾúÌ屨ÐëÖØÐ¸ÐȾËÞÖ÷ϸ°ûÒÔ±ã»ñµÃ×ã¹»µÄ²¡¶¾Á£×Ó ½øÐÐÏÂÒ»ÂÖɸѡ£¬ÖØ×鲡¶¾Á£×Ó¼ä¸ÐȾÄÜÁ¦µÄ²î±ð»áÔì³ÉÒ»¶¨µÄÀ©ÔöÓÅÊÆ£»( ÊɾúÌå Ò×±»¿ÕÆø´«²¥£¬Òò¶øÈÝÒ×ÒýÆð½»²æÎÛȾ¡£·¢Ã÷ÄÚÈÝ
±¾·¢Ã÷µÄÄ¿µÄÊÇÌṩһÖÖ·ÖÎöµ°°×µÄ¿¹Ô±íλµÄ·½·¨¡£
±¾·¢Ã÷ÌṩµÄ·ÖÎöµ°°×µÄ¿¹Ô±íλµÄ·½·¨£¬°üÀ¨Èçϲ½Öè
(1)¹¹½¨Ä¿µÄµ°°×µÄDNAÎĿ⣻ËùÊöDNAÎÄ¿âÖУ¬ËùÊöÄ¿µÄµ°°×µÄ±àÂë»ùÒòµÄ DNAƬ¶Î²åÈëTÔØÌ壻ËùÊöTÔØÌ庬ÓнÍĸaÄý¼¯ËØAga2pµÄ±àÂë»ùÒò£¬ÇÒËùÊöDNA Ƭ¶Î±àÂëµÄëÄÆ¬¶ÎµÄN¶ËÓëËùÊö½ÍĸaÄý¼¯ËØAga2pµÄC¶ËÈںϣ»
(2)½«ËùÊöDNAÎÄ¿âչʾÔÚ½Íĸ±íÃæ£¬µÃµ½½ÍĸչʾÎĿ⣻
(3)½«Ä¿µÄµ°°×µÄ¿¹ÌåÓë½ÍĸչʾÎÄ¿â»ìºÏ£¬·ÖÑ¡³öÓ뿹Ìå½áºÏµÄ½Íĸ£»
(4)½«É¸Ñ¡³öµÄ½ÍĸÌáÈ¡ÖÊÁ£½øÐвâÐò£¬¸ù¾Ý²åÈëËùÊöTÔØÌåµÄDNAƬ¶ÎµÄºË ÜÕËáÐòÁзÖÎöµ°°×µÄ¿¹Ô±íλ(°üÀ¨ÏßÐͱíλºÍ¹¹ÏóÐͱíλ)¡£
ËùÊöTÔØÌåΪÔÚPCTC0N2ÖÊÁ£µÄNhe IºÍBamH IλµãÖ®¼ä²åÈëÐòÁбíµÄÐòÁÐ ±í3×Ô5¡¯Ä©¶ËµÚ11ÖÁ40λºËÜÕËáËùʾµÄDNAµÃµ½µÄpCTC0N2_TÖÊÁ££»ËùÊöÄ¿µÄµ° °×µÄDNAƬ¶Î²åÈëËùÊöpCTC0N2-TÖÊÁ£µÄXcm IøÇÐλµã¡£
ËùÊö½ÍĸΪÄð¾Æ½Íĸ£¬ÓÅѡΪÄð¾Æ½ÍĸEBY100¡£
ËùÊö·½·¨ÖУ¬¿ÉÀûÓÃÁ÷ʽϸ°ûÊõ(FACS)½øÐв½Öè(3)ÖеÄËùÊö·ÖÑ¡¡£3
²½ÖèO)ÖУ¬½«ËùÊöDNAÎÄ¿âչʾÔÚËùÊö½Íĸ±íÃæ°üÀ¨Èçϲ½Öè
¢ÙÌáÈ¡ËùÊöDNAÎÄ¿âµÄÖÊÁ£×ª»¯ËùÊö½Íĸ£¬µÃµ½ÖØ×é½Íĸ£»
¢ÚÊÕ¼¯ÖØ×é½ÍĸÓÕµ¼ÅàÑø36СʱÒÔÉÏ£¬µÃµ½½ÍĸչʾÎĿ⣻ËùÊöÓÕµ¼ÊÇͨ¹ýÏò ÅàÑø½ÍĸµÄÌåϵÖмÓÈë°ëÈéÌÇʵÏֵġ£
ËùÊöÓÕµ¼ÅàÑøµÄ²ÎÊý¾ßÌå¿ÉΪ²ÉÓÃSGCAAÅàÑø»ù£¬20¡ãC¡¢250rpmÒ¡´²ÖÐÅà Ñø36Сʱ¡£SGCAAÅàÑø»ùµÄÅä·½¾ßÌåΪ°ëÈéÌÇ20g£¬½ÍĸµªÔ´6.7g£¬ËáË®½âÀÒËØÏ࣬ NaHPO4 ¡¤ 12H20 13.6g, NaH2PO4 ¡¤ H2O 8.56g,¼ÓÖØÕôË®ÖÁ 1L¡£
¹¹½¨ËùÊöDNAÎÄ¿âµÄ·½·¨°üÀ¨Èçϲ½Öè
(1)½«Ä¿µÄµ°°×µÄ±àÂë»ùÒòÓÃDNase I½øÐÐÏû»¯£¬»ØÊÕ50_100bpµÄDNAƬ¶Î£»
(2)½«²½Öè(1)»ØÊÕµÄDNAƬ¶Î½øÐÐËæ»úƬ¶ÎÖØ×飻
(3)½«²½Öè¢ÆÖØ×éºóµÄDNAƬ¶Î¼ÓAβ£»
(4)½«¼ÓAβºóµÄDNAƬ¶Î²åÈëËùÊöpCTCON2_TÖÊÁ£µÄXcm IøÇÐλµã£¬È»ºóת»¯ËÞÖ÷¾ú£¬µÃµ½ËùÊöDNAÎĿ⡣
ËùÊöËæ»úƬ¶ÎÖØ×éµÄ·´Ó¦Ìåϵ¾ßÌå¿ÉΪ90ngСƬ¶ÎDNA£¬4¦Ì1 5XPhire buffer, 0.8 ¦Ì 1 dNTPs, 0.5 ¦Ì 1 Phire DNA ¾ÛºÏø(1 ¸öµ¥Î»)£¬Á¦Úà ddH20 ÖÁ 20 ¦Ì 1¡£ËùÊöËæ»úƬ¶ÎÖØ×éµÄ·´Ó¦³ÌÐò¾ßÌå¿ÉΪ95¡ãC 2·ÖÖÓ£»94¡ãC 1·ÖÖÓ£¬55¡ãC 1·ÖÖÓ£¬72¡ãC NÃëÖÓ£¬ 10¸öÑ»·»ò15¸öÑ»·£»72¡ãC 10·ÖÖÓ£»µÚ1¸öÑ»·Ê±£¬NΪ60Ã룬×ÔµÚ2¸öÑ»·¿ªÊ¼£¬ ÿ¸öÑ»·±ÈÉϸöÑ»·NÔö¼Ók (¼´µÚ2¸öÑ»·Ê±£¬NΪ65Ã룬µÚ3¸öÑ»·Ê±NΪ70Ã룬 ÒÔ´ËÀàÍÆ)¡£ËùÊö·´Ó¦³ÌÐòÖУ¬ÓÅÑ¡10¸öÑ»·»ò15¸öÑ»·¡£
Ò²¿ÉÓÃÎïÀí¼ôÇз¨¡¢Ëæ»úÒýÎïÀ©Ôö·¨ºÍøÏû»¯·¨µÈ·½·¨¹¹½¨Ä¿±êµ°°×µÄDNAÎĿ⡣
ËùÊöÄ¿µÄµ°°×µÄ¿¹Ìå¿ÉΪ¶à¿Ë¡¿¹Ìå(ÈçÉ̹ºµÄ¶à¿Ë¡¿¹Ìå»òÓÃÄ¿µÄµ°°×ÃâÒß ¶¯ÎïµÃµ½µÄ¶à¿Ë¡¿¹Ìå)»òµ¥¿Ë¡¿¹Ìå¡£
ËùÊöËÞÖ÷¾ú¿ÉΪ´ó³¦¸Ë¾ú£¬ÓÅÑ¡´ó³¦¸Ë¾úDH5a¡£
ËùÊöÄ¿µÄµ°°×¿ÉΪÐòÁбíµÄÐòÁÐ1ËùʾµÄµ°°×(H5N1ÇÝÁ÷¸Ð²¡¶¾µÄHAµ°°×)¡£ ËùÊöÄ¿µÄµ°°×µÄ±àÂë»ùÒòÓÅÑ¡ÐòÁбíµÄÐòÁÐ2ËùʾµÄDNA¡£
±¾·¢Ã÷»¹±£»¤pCTCON2-TÖÊÁ££¬ÊÇÔÚpCTCON2ÖÊÁ£µÄNhe IºÍBamH IλµãÖ®¼ä²åÈëÐòÁбíµÄÐòÁбí3×Ô5¡¯Ä©¶ËµÚ11ÖÁ40λºËÜÕËáËùʾµÄDNAµÃµ½µÄ¡£
±¾·¢Ã÷»¹±£»¤-ÖÖ½Íĸ±íÃæÕ¹Ê¾ÏµÍ³£¬°üÀ¨ËùÊöpCTCON2-TÖÊÁ£ºÍ½Íĸ¡£
ËùÊö½Íĸ¿ÉΪÄð¾Æ½Íĸ£¬ÓÅѡΪÄð¾Æ½ÍĸEBY100¡£
ÉÏÊö·½·¨»ùÓÚÈçÏÂÔÀíÐźÅëÄÒýµ¼ÍâÔ´¶àëÄÏòϸ°ûÍâ·ÖÃÚ£¬ÍâÔ´¶àëÄÆ¬¶ÎµÄ N¶ËÓë½ÍĸaÄý¼¯ËØAga2pµÄC¶ËÈÚºÏ(320¸ö°±»ùËá²Ð»ù£¬º¬ÓÐGPIêµÄÐźÅÐòÁÐ)£¬ ¿Éͨ¹ýAga2p궨µ½½Íĸ±íÃæµÄAgalpÊÜÌ壬´Ó¶ø±©Â¶ÔÚ½Íĸϸ°û±íÃæ¡£
ÓëÊɾúÌåչʾÏà±È£¬½Íĸ±íÃæÕ¹Ê¾ÏµÍ³ÔÚ¹¹½¨ºÍɸѡµ°°×ÎÄ¿â·½Ãæ¾ßÓжÀµ½µÄ Óŵã(1)½Íĸϸ°û¶Ôµ°°×µÄÐÞÊÎ;¾¶¸ü¶à£¬¿ÉÒÔ·½±ãµØÕ¹Ê¾´ó·Ö×ÓÁ¿ºÍ¸´Ôӵĵ°°×£¬ ÒÔ¸üºÃµÄÄ£Äâ¿Õ¼ä¹¹Ïó£»( ½Íĸ¿É²ÉÓÃFACSÖð¸öɸѡ£¬´ó´óÌá¸ß׼ȷÐÔÓëɸѡͨÁ¿£» (3)½Íĸ¿É¶ÀÁ¢Íê³É×ÔÉíµÄÉú³¤¸´Öƹý³Ì£¬²Ù×÷¼ò±ã£¬¸ÉÈÅÒòËØÉÙ£»(4)½Íĸ²»Ò×±»¿ÕÆø ´«²¥£¬²»Ò×½»²æ¸ÐȾ¡£
ͼ1Ϊ±íÃæÕ¹Ê¾HA¡¢HAU HA2µÄ½ÍĸµÄÁ÷ʽ¼ì²â½á¹û¡£
ͼ2Ϊӫ¹âÏÔ΢¾µÏ¹۲ìHAÔÚÖØ×é½Íĸ¼×±íÃæÕ¹Ê¾µÄÇé¿ö¡£
ͼ3ΪH5N1-HAµ°°×µÄ¿¹Ô±íλµÄ·ÖÎöÁ÷³Ìͼ¡£
ͼ4Ϊ¹¹½¨H5N1-HAµ°°×µÄDNAÎÄ¿â¹ý³ÌÖеÄ1 %ÇíÖ¬ÌÇÄý½ºµçӾͼ¡£
ͼ5ΪFACS·ÖѡǰºóµÄFACS·ÖÎö½á¹û(¸»¼¯Ð§¹û)¡£
ͼ6Ϊ·ÖÑ¡µÃµ½µÄ²¿·Öµ¥¸ö½Íĸ¿Ë¡µÄFACS¼ì²â½á¹û¡£
ͼ7ΪÐòÁбȶԽá¹û¡£
ͼ8ΪƵÂÊͳ¼Æ½á¹û¡£
ͼ9ΪѪÇåÓÅÊÆÊ¶±ðÇøÓò¡£
¾ßÌåʵʩ·½Ê½
ÒÔϵÄʵʩÀý±ãÓÚ¸üºÃµØÀí½â±¾·¢Ã÷£¬µ«²¢²»ÏÞ¶¨±¾·¢Ã÷¡£ÏÂÊöʵʩÀýÖеÄʵ Ñé·½·¨£¬ÈçÎÞÌØÊâ˵Ã÷£¬¾ùΪ³£¹æ·½·¨¡£FACS·ÖÎöºÍ·ÖÑ¡²ÉÓÃAriaIIÁ÷ʽϸ°ûÒǽøÐС£ ÏÂÊöʵʩÀýÖÐËùÓõÄÊÔÑé²ÄÁÏ£¬ÈçÎÞÌØÊâ˵Ã÷£¬¾ùΪ×Ô³£¹æÉú»¯ÊÔ¼ÁÉ̵깺ÂòµÃµ½µÄ¡£ ÒÔÏÂʵʩÀýÖе͍Á¿ÊÔÑ飬¾ùÉèÖÃÈý´ÎÖØ¸´ÊµÑ飬½á¹ûȡƽ¾ùÖµ¡£
pCTCON2ÖÊÁ£(½ÍÄ¸Õ¹Ê¾ÔØÌå)ÓÉMIT Dane Wittrup½ÌÊÚ»ÝÔù£¬¹«ÖÚ¿ÉÒÔ´ÓÇå »ª´óѧ»ñµÃ£»²Î¿¼ÎÄÏ×Chao, G.£¬etal.£¬Isolating and engineering humanantibodies using yeast surface display.NATURE PROTOCOLS, 2006.1(2) p.755-768)¡£
Äð¾Æ½ÍĸEBYlOO invitrogen¹«Ë¾£¬²úƷĿ¼ºÅC839-00¡£BiomedÖÊÁ£Ð¡Ìá ÊÔ¼ÁºÐ²©ÂõµÂ¹«Ë¾¡£´ó³¦¸Ë¾úDH5 ¦Á Ìì¸ù¹«Ë¾¡£Phire DNA¾ÛºÏø(Phire hot-start DNAPolymerase) New England Biolabs¡£µ¥Á´ carrier DNA (öÙÓ㾫 DNA) Merck ¹«Ë¾£¬ ²úƷĿ¼ºÅCB262012o
YPDÅàÑø»ùÆÏÌÑÌÇ2g£¬µ°°×ëË2g£¬½ÍĸÌáÈ¡Îïlg£¬¼ÓÖØÕôË®ÖÁ100ml¡£
SDCAAÅàÑø»ùÆÏÌÑÌÇ20g£¬½ÍĸµªÔ´6.7g£¬ËáË®½âÀÒËØ5g£¬NaHPO4 ¡¤ 12H20 13.6g£¬NaH2PO4 ¡¤ H2O 8.56g£¬¼ÓÖØÕôË®ÖÁ 1L¡£
SDCAAƽ°åÆÏÌÑÌÇ20g£¬½ÍĸµªÔ´6.7g£¬ËáË®½âÀÒËØ5g£¬ÇíÖ¬·Û15g£¬ NaHPO4 ¡¤ 12H2013.6g, NaH2PO4 ¡¤ H2O 8.56g,¼ÓÖØÕôË®ÖÁ 1L¡£
SGCAAÅàÑø»ù°ëÈéÌÇ20g£¬½ÍĸµªÔ´6.7g£¬ËáË®½âÀÒËØ5g£¬NaHPO4 ¡¤ 12H20 13.6g£¬NaH2PO4 ¡¤ H2O 8.56g£¬¼ÓÖØÕôË®ÖÁ 1L¡£
ʵʩÀý1¡¢pCTCON2ÖÊÁ£ºÍ½ÍĸչʾÍâÔ´µ°°×ÄÜÁ¦µÄÆÀ¼Û
1¡¢ÖØ×éÖÊÁ£µÄ¹¹½¨
½«H5N1-HAµ°°×µÄ±àÂë»ùÒò(H5N1ÇÝÁ÷¸Ð²¡¶¾µÄHAµ°°×£¬ÈçÐòÁбíµÄÐòÁÐ1 Ëùʾ£¬Æä±àÂë»ùÒòÈçÐòÁбíµÄÐòÁÐ2Ëùʾ)²åÈëpCTCON2ÖÊÁ£µÄNhe IºÍBamH Iλµã Ö®¼ä£¬µÃµ½ÖØ×éÖÊÁ£¼×¡£
½«H5N1-HA1µ°°×µÄ±àÂë»ùÒò(ÈçÐòÁбíµÄÐòÁÐ2×Ô5¡¯Ä©¶ËµÚ1_987λºËÜÕ ËáËùʾ£¬±àÂëÐòÁбíµÄÐòÁÐ1×ÔNÄ©¶ËµÚ1ÖÁ3 λËùʾµÄ°±»ùËá²Ð»ù)²åÈëpCTCON2 ÖÊÁ£µÄNhe IºÍBamH IλµãÖ®¼ä£¬µÃµ½ÖØ×éÖÊÁ£ÒÒ¡£
½«H5N1-HA2µ°°×µÄ±àÂë»ùÒò(ÈçÐòÁбíµÄÐòÁÐ2×Ô5¡¯Ä©¶ËµÚ988-1545λºËÜÕËáËùʾ£¬±àÂëÐòÁбíµÄÐòÁÐ1×ÔNÄ©¶ËµÚ330ÖÁ515λËùʾµÄ°±»ùËá²Ð»ù)²åÈëpCTCON2 ÖÊÁ£µÄNhe IºÍBamH IλµãÖ®¼ä£¬µÃµ½ÖØ×éÖÊÁ£±û¡£
2¡¢ÖØ×é½ÍĸµÄ»ñµÃ
½«ÖØ×éÖÊÁ£¼×ת»¯½Íĸ¾úÖêEBY100£¬µÃµ½ÖØ×é½Íĸ¼×¡£
½«ÖØ×éÖÊÁ£ÒÒת»¯½Íĸ¾úÖêEBY100£¬µÃµ½ÖØ×é½ÍĸÒÒ¡£
½«ÖØ×éÖÊÁ£±ûת»¯½Íĸ¾úÖêEBY100£¬µÃµ½ÖØ×é½Íĸ±û¡£
3¡¢ÍâÔ´µ°°×µÄÓÕµ¼±í´ï
·Ö±ð½«ÖØ×é½Íĸ¼×¡¢ÖØ×é½ÍĸÒÒºÍÖØ×é½Íĸ±û½øÐÐÓÕµ¼±í´ï£¬È»ºóÓÃH5N1-HA µ°°×ÃâÒßµÄСÊóѪÇåºÍFITCÓ«¹â±ê¼ÇµÄ¿¹Ð¡ÊóµÄ¶þ¿¹½øÐнÍĸȾɫ£¬×îºó·Ö±ðÀûÓà FACS¼ì²âºÍÓ«¹âÏÔ΢¾µ¼ì²â±íÃæÕ¹Ê¾Çé¿ö¡£
FACS¼ì²â½á¹û¼ûͼ1;ͬÒõÐÔ¶ÔÕÕÏà±È£¬ÈýÖÖ½Íĸ¶¼Äܱ»Ó«¹â±ê¼Ç£¬³öÏÖÁËÒ» ¸öÑôÐԷ壻±È½ÏHAlºÍHA2µÄÁ÷ʽ½á¹û»¹¿ÉÒÔ¿´³ö£¬HAl½ÍĸµÄÓ«¹âÇ¿¶È±ÈHA2½Íĸ µÄÓ«¹âÇ¿¶ÈҪǿ£¬Õâ·´Ó³ÁËÔÚH5N1-HAµ°°×ÃâÒßµÄСÊó¶à¿¹ÑªÇåÖУ¬´ó²¿·Ö¿¹ÌåÊÇÕë¶Ô HAlµÄ¡£ÖØ×é½Íĸ¼×µÄÓ«¹âÏÔ΢¾µ¼ì²â½á¹û¼ûͼ2£¬ÔÚÓ«¹âÏÔ΢¾µÏ¿ÉÒԹ۲쵽£¬½Íĸ ±íÃæÓÐÂÌɫӫ¹â¡£ÒÔÉÏÁ½¸ö½á¹û±íÃ÷½ÍĸչʾϵͳÄܹ»ºÜºÃµÄ¹¤×÷¡£
ʵʩÀý2¡¢pCTCON2-TÖÊÁ£(ÖØ×é½ÍÄ¸Õ¹Ê¾ÔØÌå)µÄ¹¹½¨
ΪÁ˱ãÓÚ½¨¿â£¬ÐèÒª½«pCTCON2ÖÊÁ£¸ÄÔì³ÉTÔØÌ壬²½ÖèÈçÏÂ
1¡¢ºÏ³ÉÐòÁбíµÄÐòÁÐ3ËùʾµÄDNA(Ë«Á´)¡£
5£¬ -AGTCGCTAGC CCAGGGATAGGGTGGCCACCCTATCCCTGGGGATCCGGGT-3£¬(ÐòÁÐ 3)¡£
×ó±ßµÄÏ»®Ïß±ê×¢Nhe Iʶ±ðÐòÁУ¬ÓұߵÄÏ»®Ïß±ê×¢BamH Iʶ±ðÐòÁУ¬´ÖÌå ±ê×¢Á½¸öXcm Iʶ±ðÐòÁС£
2¡¢ÓÃÏÞÖÆÐÔÄÚÇÐøNhe IºÍBamH I˫øÇв½Öè1ºÏ³ÉµÄDNA£¬»ØÊÕøÇвúÎï¡£
3¡¢ÓÃÏÞÖÆÐÔÄÚÇÐøNhe IºÍBamH I˫øÇÐpCTCON2ÖÊÁ££¬»ØÊÕÔØÌå¹Ç¼Ü¡£
4¡¢½«²½Öè2µÄøÇвúÎïºÍ²½Öè3µÄÔØÌå¹Ç¼ÜÁ¬½Ó£¬µÃµ½pCTCON2-TÖÊÁ£(¹Ç ¼ÜÔØÌåΪpCTCON2ÖÊÁ££¬ÔڹǼÜÔØÌåµÄNhe IºÍBamH IλµãÖ®¼ä²åÈëÁËÐòÁбí3×Ô5£¬ Ä©¶ËµÚ11ÖÁ40λºËÜÕËáËùʾµÄDNA)¡£pCTCON2-TÖÊÁ£ÔÚpCTCON2ÖÊÁ£ÀïÒýÈëÁËÁ½ ¸öXcm IøÇÐλµã£¬ÓÃÏÞÖÆÐÔÄÚÇÐøXcm IøÇлáÐγÉTβ¡£
ʵʩÀý3¡¢Ó¦Óñ¾·¢Ã÷µÄ·½·¨·ÖÎöH5N1-HAµ°°×µÄ¿¹Ô±íλ
Ó¦Óñ¾·¢Ã÷µÄ·½·¨É¸Ñ¡H5N1-HAµ°°×µÄ¿¹Ô±í룬Á÷³ÌÈçͼ3Ëùʾ¡£Ê×ÏÈËæ »úÇиîH5N1-HAµ°°×µÄ±àÂë»ùÒò²¢½øÐÐÖØ×飬µÃµ½Ëæ»úƬ¶Î£»½«Ëæ»úƬ¶Îͨ¹ýT-AÁ¬ ½Ó²åÈëPCTCON2-TÖÊÁ££»È»ºóת»¯Äð¾Æ½Íĸ£¬ÓÕµ¼±í´ïºó¶àÖÖÈں϶àëÄ(Ëæ»úƬ¶Î±àÂë µÄ¶àëÄÓëAga2µ°°×µÄC¶ËÈÚºÏ)չʾÔÚÄð¾Æ½Íĸ±íÃæ(½ÍĸչʾÎÄ¿â)£»Í¨¹ýH5N1-HA µ°°×µÄ¿¹Ìå(¶à¿Ë¡¿¹Ìå»òµ¥¿Ë¡¿¹Ìå)½øÐÐFACS·ÖÑ¡£¬»ñµÃÓ뿹Ìå½áºÏµÄÖØ×é½Íĸ£» ½«¸÷¸öɸѡµÃµ½µÄÖØ×é½ÍĸÌáÖÊÁ£²âÐò£¬¸ù¾Ý²âÐò½á¹û½øÐп¹Ô¿¹ÌåÏ໥×÷ÓõÄÑо¿¡£
Ò»¡¢¹¹½¨H5N1-HAµ°°×µÄDNAÎÄ¿â(H5N1-HAËæ»úÇÐ¸îÆ¬¶ÎÎÄ¿â)
¹¹½¨H5N1-HAµ°°×µÄDNAÎĿ⣬Ê×ÏȽ«H5N1-HAµ°°×µÄ±àÂë»ùÒòͨ ¹ýDNaseI½øÐÐËæ»úÇи»ñµÃÔ¼50_100bpµÄСƬ¶Î£¬È»ºóͨ¹ýËæ»úÖØ×éµÃµ½¾ßÓÐÌØ ¶¨³¤¶È·Ö²¼µÄËæ»úƬ¶Î DNA ÎÄ¿â(Lin£¬¦¦.£¬S.Li and Y.Chen, Identification of ViralPeptideFragments for Vaccine Development.Viral Applications of Green FluorescentProtein Methods and Protocols, 2009 p.261-274. £» Chen, Y., et al.£¬Randomdissection to select for protein split sites and its application in proteinfragment complementation.PROTEIN SCIENCE, 2009.18 (2) p.399-409.)¡£ÉÏÊö·½·¨·Ç³£ÀàËÆÓÚ DNA shuffling µÄ³ÌÐò (Lorimer, Land I.Pastan, Randomreeombination of antibody single-chain fv sequences after fragmentation withdnasei in the presence of Mn2+.Nucleic Acids Res, 1995.23 (15) p.3067-3608.),ÇÉÃîµØÀûÓÃÆ¬¶ÎÖØ×é¹ý³ÌÀ´µ÷½ÚËæ»úƬ¶ÎDNAÎÄ¿âµÄ·Ö²¼£¬¿É¸ù¾Ýɸѡ ÐèÒª¹¹½¨¸üΪºÏÀíµÄÎĿ⣬Ϊ»ñµÃ¹Ø¼üµÄ¹¹ÏóÐÍ¿¹Ô±íλÌṩ»ù´¡¡£
1¡¢´óÁ¿À©ÔöÄ¿µÄ»ùÒò
¢Ù½øÐÐÄ¿µÄ»ùÒòPCRÀ©Ôö
ºÏ³ÉÐòÁбíµÄÐòÁÐ2ËùʾµÄH5N1-HAµ°°×µÄ±àÂë»ùÒò£¬×÷Ϊģ°å£¬ÓÃHA_FºÍ HA-R×é³ÉµÄÒýÎï¶Ô½øÐÐPCRÀ©Ôö£¬µÃµ½PCRÀ©Ôö²úÎï(Ä£°åDNA)¡£Ä£°åDNAµÄÇí Ö¬ÌÇÄý½ºµçӾͼ¼ûͼ4µÄÓ¾µÀA¡£
HA-F 5£¬-GATCAGATTTGCATTGGTTA-3£¬£»
HA-R 5£¬-TATTTGGTAAGTTCCTATTG-3£¬¡£
¢Ú²ÉÓÃQIAquick PCR Purification Kit´¿»¯»ØÊÕPCRÀ©Ôö²úÎ½øÐÐDNA¶¨Á¿ (DNAµÄŨ¶ÈÓ¦´óÓÚ130ng/ ¦Ì 1)¡£
2¡¢DNase I Ëæ»úÏû»¯
¢Ù×¼±¸DNase I µ×ÎïÈÜÒº£»4 ¦Ì g Ä£°å DNA¡¢2.5 ¦Ì 1 IM Tris-Cl (¦Ñ¦§7.5)£¬10 ¦Ì 1 50mMMnCl2,Á¦¿Ú ddH20 ÖÁ 49 ¦Ì 1¡£
¢Ú¼ÓÈë1 ¦Ì 1 DNaseI(0.075U)(¹º×Ô Worthington ¹«Ë¾£¬²úƷĿ¼ºÅ LS006361)£¬ 15¡ãC ·´Ó¦ 4min¡£
¢Û¼ÓÈë10 ¦Ì 1 0.5¦¬ EDTAË®ÈÜÒºÖÕÖ¹·´Ó¦¡£
¢Ü90¡ãC·ÅÖÃ10·ÖÖÓ£¬½øÒ»²½Ê¹DNase Iʧ»î¡£
3¡¢´¿»¯DNase IøÇÐÆ¬¶Î²úÎï
¢ÙʹÓÃPall³¬ÂËŨËõÀëÐĹÜ(½ØÁô·Ö×ÓÁ¿Îª30K)¹ýÂËÈ¥³ý²½Öè2µÄ·´Ó¦ÌåϵÖÐ µÄÄ£°åDNA¡£
¢Ú½«²½Öè¢ÙÊÕ¼¯µÄÂËҺͨ¹ýPall³¬ÂËŨËõÀëÐĹÜ(½ØÁô·Ö×ÓÁ¿Îª3K)£¬»ØÊÕ·Ö ×ÓÁ¿Îª3KÒÔϵÄСƬ¶ÎDNA¡£²ÉÓÃNanodrop 2000·Ö¹â¹â¶È¼Æ(rThermo)È·¶¨DNAŨ¶È¡£
²½Öè¢ÚµÃµ½µÄСƬ¶ÎDNAµÄÇíÖ¬ÌÇÄý½ºµçӾͼ¼ûͼ4µÄÓ¾µÀB£¬´óСΪ 50-100bp¡£
4¡¢Ð¡Æ¬¶ÎDNAµÄÖØ×é
½«²½Öè3µÃµ½µÄСƬ¶ÎDNA½øÐÐËæ»úƬ¶ÎÖØ×飬µÃµ½Ëæ»úƬ¶Î¡£
ÖØ×é·´Ó¦Ìåϵ90ngСƬ¶Î DNA£¬4 ¦Ì 1 5 XPhire buffer, 0.8 ¦Ì 1 dNTPs, 0.5 ¦Ì 1 PhireDNA¾ÛºÏø(1¸öµ¥Î»)£¬¼ÓddH20ÖÁ20 ¦Ì 1¡£
ÖØ×é·´Ó¦³ÌÐò95¡ãC 2·ÖÖÓ£»94¡ãC 1·ÖÖÓ£¬55¡ãC 1·ÖÖÓ£¬72¡ãC NÃëÖÓ£¬10¸öÑ »·»ò15¸öÑ»·£»72¡ãC 10·ÖÖÓ£»4¡ãC±£´æ¡£µÚ1¸öÑ»·Ê±£¬NΪ60Ã룬×ÔµÚ2¸öÑ»·¿ª ʼ£¬Ã¿¸öÑ»·±ÈÉϸöÑ»·NÔö¼Ó¼´µÚ2¸öÑ»·Ê±£¬NΪ65Ã룬µÚ3¸öÑ»·Ê±NΪ70Ã룬ÒÔ´ËÀàÍÆ)
µÃµ½µÄËæ»úƬ¶ÎÓÃQIAquick PCR Purification Kit´¿»¯²¢¶¨Á¿ÆäŨ¶È¡£
10¸öÑ»·µÃµ½µÄËæ»úƬ¶ÎµÄÇíÖ¬ÌÇÄý½ºµçӾͼ¼ûͼ4µÄÓ¾µÀC£¬´óСΪ 100-500bp¡£15¸öÑ»·µÃµ½µÄËæ»úƬ¶ÎµÄÇíÖ¬ÌÇÄý½ºµçӾͼ¼ûͼ4µÄÓ¾µÀD£¬´óСΪ 200-800bp¡£½«15¸öÑ»·µÃµ½µÄËæ»úƬ¶Î½øÐв½Öè5¡£
5¡¢Ëæ»úƬ¶Î¼ÓAβ
½«²½Öè4µÃµ½µÄËæ»úƬ¶Î²ÉÓæ¡-tailing DNAKit(Takara)°´ÊÔ¼ÁºÐµÄ˵Ã÷Êé¼ÓA⣬¾ßÌå²½ÖèÈçÏÂ
ÔÚ΢Á¿ÀëÐĹÜÖÐÅäÖÆÈçϼӡ°A¡±·´Ó¦Òº(50ul) IOXA-Tailing Buffer 5 ¦Ì 1, dNTP Mixture 4 ¦Ì 1£¬¦¡-Tailing Enzyme 0.5 ¦Ì 1£¬Ëæ»úƬ¶Î 2 ¦Ì g£¬Á¦¿Ú ddH20 ÖÁ 50 ¦Ì 1 £» 72¡ãC·´Ó¦20·ÖÖÓ£¬È»ºó±ùÔ¡4·ÖÖÓ£»È»ºóÓÃQIAquick PCR Purification Kit´¿»¯£¬²¢Óà Nanodrop2000·Ö¹â¹â¶È¼Æ¶¨Á¿DNAƬ¶ÎŨ¶È¡£
6¡¢¹Ç¼ÜÔØÌåµÄÖÆ±¸
ÓÃÏÞÖÆÐÔÄÚÇÐøøÇÐpCTCON2-TÖÊÁ££¬µÃµ½¹Ç¼ÜÔØÌå¡£
øÇÐÌåϵpCTCON2-TÖÊÁ£ 24 ¦Ì g£¬10XNEB buffer2 10 ¦Ì 1£¬10XBSA 1 ¦Ì 1£¬ ÏÞÖÆÐÔÄÚÇÐøXcm I 2 ¦Ì 1£¬Á¦ÚàddH20ÖÁ100 ¦Ì 1¡£
·´Ó¦Ìõ¼þ37¡ãCˮԡ3-6Сʱ¡£
²ÉÓÃQIA quick Gel Extraction ICit»ØÊÕøÇвúÎï¡£½«»ØÊյĸÇвúÎïÓà QIAquickPCR Purification Kit´¿»¯£¬²¢ÓÃNanodrop2000·Ö¹â¹â¶È¼Æ¶¨Á¿DNAƬ¶ÎŨ¶È¡£
7¡¢Ëæ»úƬ¶Î¿âÓëÔØÌåµÄ½áºÏ
½«²½Öè5¼Ó¡°A¡±ºóµÄËæ»úƬ¶ÎºÍ²½Öè6µÄ¹Ç¼ÜÔØÌåºãνðÊôÔ¡16¡ãCÁ¬½Ó¹ý Ò¹(12СʱÒÔÉϾù¿É)¡£Á¬½ÓÌåϵ10XT4 ligase buffer 20 ¦Ì 1£¬Á¦Úà¡°¦¡¡±ºóµÄËæ»úƬ¶Î (1 ¦Ì g)£¬¹Ç¼ÜÔØÌå(4 ¦Ì g)£¬T4 ligase (New England Biolabs) 10 ¦Ì 1£¬Á¦¿Ú ddH20 M 200 ¦Ì L
8¡¢µçת
¢ÙÓÃQIAquick PCR Purification Kit´¿»¯²½Öè7µÄÁ¬½Ó»ìºÏÎï¡£
¢Ú½«´¿»¯ºóµÄƬ¶Îµçתµ½´ó³¦¸Ë¾úDH5aϸ°ûÖС£
¢ÛÍ¿LBƽ°å(º¬50mg/ml°±ÜÐÇàÃ¹ËØ)£¬37¡ãCÎÂÏäÖйýÒ¹ÅàÑø£¬´ÎÈղ鿴ת»¯ ½á¹û£¬Í³¼Æ°åÉϵľúÂäÊý(¿âÈÝÁ¿)¡£¿âÈÝÁ¿Îª500,000×óÓÒ¡£
¢Ü²ÉÓùΰåÆ÷¹Î¸É¾»LBƽ°åÉϵľúÂ䣬·ÅÈë60ml LBÅàÑø»ù(º¬lOOmg/ml°± ÜÐÇàÃ¹ËØ)£¬¼´ÎªH5N1-HAµ°°×µÄDNAÎĿ⡣
¶þ¡¢½Íĸת»¯¡¢ÅàÑøºÍÓÕµ¼
1¡¢½Íĸת»¯
ƽÐнøÐÐ10×é½Íĸת»¯£¬Ã¿×é¾ù²ÉÓÃÈçÏ·½·¨
(1)´ÓYPDƽ°åÉÏÌôȡһ¸öÐÂÏʵÄÄð¾Æ½ÍĸEBY100µ¥¿Ë¡ÖÁ5ml YPDÒºÌåÅà Ñø»ù£¬30¡ãC 250rpm¹ýÒ¹ÅàÑø£»
(2)½«¹ýÒ¹ÅàÑøÎïÏ¡ÊÍÖÁOD600ֵΪ0.4-0.5£¬ÔÚ30¡ãCÒ¡´²ÖмÌÐøÅàÑøÖÁOD600 Öµ´ïµ½2(Ô¼4Сʱ)£»
(3)ÊÒÎÂ1500gÀëÐÄ5·ÖÖÓ£¬ÆúÉÏÇ壬ÊÕ¼¯½Íĸϸ°û£»ÓÃ25mlÎÞ¾úË®ÖØÐü½Íĸ ϸ°û£¬ÊÒÎÂ1500gÀëÐÄ5·ÖÖÓ£¬ÆúÉÏÇ壬ÊÕ¼¯½Íĸϸ°û£»8
(4)ÓÃIml 0.1M´×Ëáï®ÈÜÒºÖØÐü½Íĸϸ°û£¬30Cˮԡ10·ÖÖÓ£¬È»ºó13000gÀëÐÄ5s,ÆúÉÏÇ壬ÊÕ¼¯½Íĸϸ°û£»
(5)ÓÃ0.5ml 0.1M´×Ëáï®ÈÜÒºÖØÐü½Íĸϸ°û£¬50ulÿ¹Ü·Ö×°(¸ÐÊÜ̬ϸ°û)£»
(6)½«µ¥Á´carrier DNA·ÅÈë·ÐË®ÖÐˮԡ5·ÖÖÓ£¬È»ºóÁ¢¼´È¡³ö±ùÔ¡£»
(7)²ÉÓÃBiomedÖÊÁ£Ð¡ÌáÊÔ¼ÁºÐ(²©ÂõµÂ)ÌáÈ¡²½ÖèÒ»µÃµ½µÄDNAÎÄ¿âµÄÖÊ Á££¬½«1 ¦Ì gÖÊÁ£Ï¡ÊÍÖÁ50ul £»
(8)ȡһ¹Ü²½Öè( µÃµ½µÄ¸ÐÊÜ̬ϸ°û£¬13000gÀëÐÄ&£¬ÆúÉÏÇ壻ÒÀ´Î¼ÓÈë 240 ¦Ì 50% PEGÈÜÒº¡¢36 ¦Ì 1 IM ´×Ëáï®ÈÜÒº¡¢25 ¦Ì 1 µ¥Á´ carrier DNA¡¢50ul ²½Öè(7)µÄ ÖÊÁ££¬³ä·Ö»ì„ò£»30¡ãCˮԡ30·ÖÖÓ£¬È»ºó42¡ãCˮԡ15·ÖÖÓ£»13000gÀëÐÄ&£¬ÆúÉÏÇ壬 ÊÕ¼¯½Íĸϸ°û£»
(9)ÓÃImlÎÞ¾úË®ÖØÐü½Íĸϸ°û£¬È¡³öIOOulÍ¿SDCAAƽ°å£¬ÔÚ30¡ãCºãÎÂÏäÖÐ ·ÅÖÃÔ¼48Сʱ£¬ÄÜ¿´µ½Ã÷ÏԵľúÂ䣬ͳ¼Æ¾úÂäÊý£¬¼ÆËã½Íĸת»¯Ð§ÂÊ¡£Ã¿Ò»×éµÄת»¯Ð§ ÂÊ(¾úÂäÊý)Ϊ50,000-100,000,10×éµÄ¿âÈÝÁ¿¾ÍÊÇ500,000-1000,000£¬Äܹ»º¸Çͨ¹ýÀíÂÛ ¼ÆËãµÄ¾ø´ó¶àÊý¿Ë¡¡£
2¡¢ÓÕµ¼
(1)ÿ×éÊ£ÓàµÄ900ul¾úÒºÓÃIOml SDCAAÖØÐüºó»ìºÏÔÚÒ»Æð£¬30¡ãC£¬250rpmÒ¡ ´²ÖÐÅàÑøÖÁOD600ԼΪ3 (24Сʱ)¡£
(2)È¡500΢Éý¾úÒº£¬ÊÒÎÂ8000rpmÀëÐÄ1·ÖÖÓ£¬ÆúÉÏÇ壬ÓÃIml SGCAAÅàÑø»ùÖØÐüϸ°û£¬È»ºóÏ¡ÊÍÖÁOD600ÔÚ0.5-1Ö®¼ä£»
(3) 200C 250rpmÒ¡´²ÖÐÓÕµ¼36Сʱ£¬µÃµ½µÄ¾úÒº¼´Îª½ÍĸչʾÎĿ⡣
Èý¡¢½ÍĸչʾÎÄ¿âµÄFACS·ÖÑ¡¼°FACS·ÖѡЧ¹ûÆÀ¼Û
1¡¢É¸Ñ¡ÑªÇåµÄÖÆ±¸
ÓÃH5N1-HAµ°°×(±±¾©ÒåÇÌÉñÖÝÉúÎï¼¼Êõ¹«Ë¾»õºÅ11048-V08H1)ÃâÒß BALB/cСÊó(Öйúҽѧ¿ÆÑ§Ôº¶¯ÎïÑо¿Ëù£¬SPF¼¶)£¬²ÉÓø¹²¿Æ¤ÏÂÃâÒß×¢É䣬¹²ÃâÒß 4´Î£¬Ã¿´Î¼ä¸ô3ÖÜ£¬µÚ1´ÎÃâÒß¼ÁÁ¿Îª20ug/Ö»£¬ÆäÓà´ÎÊýÃâÒß¼ÁÁ¿ÎªIOug/Ö»£»µÚ4 ´ÎÃâÒߺóȡѪÇå×÷ΪɸѡѪÇ壻µÚ1´ÎÃâÒßǰȡѪÇå×÷ΪÒõÐÔ¶ÔÕÕѪÇå¡£
2¡¢½ÍĸչʾÎÄ¿âµÄFACS·ÖÑ¡
½«²½Öè¶þµÃµ½µÄ½ÍĸչʾÎÄ¿â½øÐÐFACS·ÖÎö»òFACS·ÖÑ¡(FACS·ÖÎöÈ¡IO6-IO7 ¸öϸ°û£¬FACS·ÖѡȡIO7-IO8¸öϸ°û)¡£FACS·ÖÎöÖÐÓÃÒõÐÔѪÇå×÷ΪɸѡѪÇåµÄ¶ÔÕÕ¡£
¢ÙÈ¡½Íĸϸ°û×°Èë1.5ml Ep¹ÜÖУ¬8000rpm(»ò> 8000rpmÒ²¿É)ÀëÐÄ1·ÖÖÓ£¬ÆúÉÏÇ壻
¢Ú¼ÓÈëlmlPBS£¬Çᵯ¹Ü±Ú½«½Íď֨Ðü£¬8000rpmÀëÐÄ1·ÖÖÓ£¬È¡³Áµí£»Öظ´´Ë²Ù×÷Ò»´Î£»
¢Û¼ÓÈëÓÃ50ul PBS 100±¶Ï¡Ê͵ÄɸѡѪÇ壬Çᵯ»ì„ò£¬±ùÔ¡1Сʱ£¬ÆÚ¼äÿ¸ô 15-20·ÖÖÓÇᵯ¹Ü±Ú£»
¢Ü¼ÓÈëlmlPBS£¬»ì„ò£¬8000rpm 4¡ãCÀëÐÄ1·ÖÖÓ£¬È¡³Áµí£»Öظ´´Ë²Ù×÷Ò»´Î£»
¢Ý¼ÓÈëÓÃ50ul PBS 100±¶Ï¡Ê͵ÄÓ«¹â±ê¼ÇµÄ¶þ¿¹(PE±ê¼ÇÑò¿¹Êó^G£¬¹º×Ô SantaCruz¹«Ë¾£¬»õºÅsc-3738)£¬Çᵯ»ì„ò£¬±ùÔ¡45·ÖÖÓ£¬ÆÚ¼äÿ¸ô15-20·ÖÖÓÇᵯ¹Ü±Ú (×¢Òâ±Ü¹â)£»
¢Þ¼ÓÈëlmlPBS£¬»ì„ò£¬8000rpm 4¡ãCÀëÐÄ1·ÖÖÓ£¬È¡³Áµí(½Íĸ)£»Öظ´´Ë²Ù×÷Ò»´Î£»
¢ßÓÃPBSÖØÐü½Íĸ(FACS·ÖÎöÓÃ0.5-lml PBS, FACS·ÖÑ¡ÓÃ3_4ml PBS)£¬×ª ÒÆµ½Á÷ʽϸ°ûÒǽøÐÐFACS·ÖÑ¡»òFACS·ÖÎö¡£
²ÉÓÃÒõÐÔѪÇåµÄFACS·ÖÎöͼÆ×¼ûͼ5A£¬²ÉÓÃɸѡѪÇåµÄFACS·ÖÎöͼÆ×¼ûͼ 5B¡£ÓëɸѡѪÇå½áºÏµÄ½Íĸϸ°ûÔ¼Õ¼2%¡£FACS·ÖÑ¡ÖÐÊÕ¼¯ÓëɸѡѪÇå½áºÏµÄ½Íĸϸ °û¡£
3¡¢FACS·ÖѡЧ¹ûÆÀ¼Û
½«²½Öè2·ÖÑ¡µÃµ½µÄ½Íĸϸ°û(10Íò-50Íò)×ªÒÆµ½ÊÔ¹ÜÖУ¬¼ÓÈëSDCAAÅà Ñø»ùÖÁ×ÜÌå»ýΪ2ml£¬½«ÊÔ¹ÜÖÃÓÚ30¡ãCÒ¡´²ÖУ¬ÈýÍĸ¸´ËÕ2-3Сʱ¡£È¡³ö200ul(´óÔ¼ 5000-10000¸ö½Íĸϸ°û)¸´ËյľúҺͿSDCAAƽ°å£¬½«Æ½°åµ¹ÖÃÔÚ30¡ãCºãÎÂÏäÖУ¬48 СʱºóÊÕ¾ú£¬µÃµ½55¸öÑôÐÔµ¥¿Ë¡£»Ê£ÓàµÄ¾úÒº¼ÓÈëSDCAAÖÁ×ÜÌå»ýΪ5ml£¬30¡ãCÒ¡ ´²ÅàÑøMСʱ(»ìºÏ¾úÒº)¡£½«Ñô¸öÑôÐÔµ¥¿Ë¡ºÍ»ìºÏ¾úÒº·Ö±ð½øÐÐÓÕµ¼£¬È»ºó½øÐÐ FACS·ÖÎö¡£ÓÕµ¼·½·¨Í¬²½Öè¶þµÄ2¡£FACS·ÖÎö·½·¨Í¬²½ÖèÈýµÄ1¡£
»ìºÏ¾úµÄFACS·ÖÎöͼÆ×¼ûͼ5C£¬ÓëɸѡѪÇå½áºÏµÄ½Íĸϸ°ûÕ¼40%×óÓÒ¡£
11¸öµ¥¿Ë¡µÄFACS·ÖÎö½á¹û¼ûͼ6¡£´Óͼ6¿ÉÒÔ¿´³ö£¬²»Í¬µÄµ¥¿Ë¡µÄͼÆ× ÊDz»Ò»ÑùµÄ£¬Õâ±íÃ÷²»Í¬µÄµ¥¿Ë¡ÓëѪÇåµÄ·´Ó¦Çé¿öÊDz»Ò»ÑùµÄ¡£
ËÄ¡¢²âÐò¼°ÐòÁзÖÎö
1¡¢¶ÔÓÚ²½ÖèÈýµÄ3ÖÐFACS·ÖÎöΪÑôÐԵĿË¡£¬À©´óÅàÑøºó£¬ÓøÊÓͶ³´æ¾úÖÖ (¸ÊÓÍÖÕŨ¶È15% )£¬Ê£ÓàÈ«²¿¾úÒºÓÃÖÊÁ£Ð¡ÌáÊÔ¼ÁºÐÌáÈ¡ÖÊÁ££»
2¡¢ÓÉÓÚ´Ó½ÍĸÖÐÌáÈ¡µÄÖÊÁ£¿½±´ÊýºÜµÍ£¬½«ÌáÈ¡µÄÖÊÁ£×ª»¯µ½´ó³¦¸Ë¾ú DH5a,È»ºó½øÐвâÐò(¼ì²â²åÈëpCTCON2-TÖÊÁ£ÖÐµÄÆ¬¶ÎµÄºËÜÕËáÐòÁÐ)¡£
3¡¢ÐòÁзÖÎö
²ÉÓÃkquencherÈí¼þ½«²åÈëµ½pCTCON2ÔØÌåÖеÄËæ»úƬ¶ÎÓëHAÈ«³¤½øÐÐÐòÁбȶԣ¬½á¹û¼ûͼ7¡£²ÉÓÃExcelÈí¼þÒÀÕÕÐòÁбȶԽá¹û½«HAÉÏÿ¸öλµãÉϰ±»ùËá³öÏÖµÄ ÆµÂʽøÐзÖÎöͳ¼Æ£¬½á¹û¼ûͼ8¡£²ÉÓÃPyMOLÈí¼þ¶Ôͳ¼Æ½á¹ûºÍµ°°×¾§Ìå½á¹¹½øÐÐ·Ö Îö£¬½á¹û¼ûͼ9¡£kquencherÈí¼þ£¬ExcelÈí¼þºÍPyMOL (Èí¼þ¾ùÎÞÌØÊâµÄ²ÎÊýÉ趨£¬¾ù °´ÕÕÈí¼þµÄ²Ù×÷ÊÖ²á½øÐзÖÎö¡£
ÌôÑ¡³öÀ´µÄƬ¶Î¶¼ÊÇÄÜÓë¶à¿Ë¡¿¹ÌåѪÇå·´Ó¦µÄƬ¶Î£¬´ÓƵÂÊͼ¾Í¿ÉÒÔ¿´³ö¶à ¿¹Ê¶±ðλµãµÄ·Ö²¼Çé¿ö¡£ÑªÇåÖ÷Ҫʶ±ðHA1£¬ÔÚHAlÓëHA2µÄ½»½ç´¦¶¼Ã»ÓÐʶ±ðλµã¡£ ѪÇåÖеĶà¿Ë¡¿¹ÌåÓÐ80%ÊÇÕë¶ÔHAlµÄ£¬20%ÊÇÕë¶ÔHA2¡£ÁíÍ⣬ѪÇåÖеĶà¿Ë¡ ¿¹ÌåÔÚHAlÇøÓòÓÐÁ½¸öÓÅÊÆÊ¶±ðÇøÓò£¬Î»ÓÚ70aa_120aaºÍ150aa_200aa£¬ÕâÁ½¸öÇøÓò¶¼Î» ÓÚHAµÄÊÜÌå½áºÏÇøÓò(ReceptorBinding Domain)£¬À¶É«ÇøÓòλÓÚ70aa_120aa£¬·ÛºìÉ«Çø ÓòλÓÚ 150aa_200aa¡£
ÖØ¸´½øÐÐÈý´ÎʵʩÀý3µÄʵÑ飬¾ùµÃµ½ÏàËÆµÄ½á¹û¡£
ȨÀûÒªÇó
1.·ÖÎöµ°°×µÄ¿¹Ô±íλµÄ·½·¨£¬°üÀ¨Èçϲ½Öè(1)¹¹½¨Ä¿µÄµ°°×µÄDNAÎĿ⣻ËùÊöDNAÎÄ¿âÖУ¬ËùÊöÄ¿µÄµ°°×µÄ±àÂë»ùÒòµÄ DNAƬ¶Î²åÈëTÔØÌ壻ËùÊöTÔØÌ庬ÓнÍĸaÄý¼¯ËØAga2pµÄ±àÂë»ùÒò£¬ÇÒËùÊöDNA Ƭ¶Î±àÂëµÄëÄÆ¬¶ÎµÄN¶ËÓëËùÊö½ÍĸaÄý¼¯ËØAga2pµÄC¶ËÈںϣ»(2)½«ËùÊöDNAÎÄ¿âչʾÔÚ½Íĸ±íÃæ£¬µÃµ½½ÍĸչʾÎĿ⣻(3)½«Ä¿µÄµ°°×µÄ¿¹ÌåÓë½ÍĸչʾÎÄ¿â»ìºÏ£¬·ÖÑ¡³öÓ뿹Ìå½áºÏµÄ½Íĸ£»(4)½«É¸Ñ¡³öµÄ½ÍĸÌáÈ¡ÖÊÁ£½øÐвâÐò£¬¸ù¾Ý²åÈëËùÊöTÔØÌåµÄDNAƬ¶ÎµÄºËÜÕËá ÐòÁзÖÎöµ°°×µÄ¿¹Ô±íλ¡£
2.ÈçȨÀûÒªÇó1ËùÊöµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚËùÊöTÔØÌåΪÔÚpCTCON2ÖÊÁ£µÄNheI ºÍBamH IλµãÖ®¼ä²åÈëÐòÁбíµÄÐòÁбí3×Ô5¡¯Ä©¶ËµÚ11ÖÁ40λºËÜÕËáËùʾµÄDNAµÃ µ½µÄpCTCON2-TÖÊÁ££»ËùÊöÄ¿µÄµ°°×µÄDNAƬ¶Î²åÈëËùÊöpCTCON2_TÖÊÁ£µÄXcm I øÇÐλµã£»ËùÊö½ÍĸΪÄð¾Æ½Íĸ£¬ÓÅѡΪÄð¾Æ½ÍĸEBY100¡£
3.ÈçȨÀûÒªÇó1»ò2ËùÊöµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚËùÊö·½·¨ÖУ¬ÀûÓÃÁ÷ʽϸ°ûÊõ½øÐв½ Öè(3)ÖеÄËùÊö·ÖÑ¡¡£
4.ÈçȨÀûÒªÇó1»ò2»ò3ËùÊöµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚ²½Öè(2)ÖУ¬½«ËùÊöDNAÎÄ¿â չʾÔÚËùÊö½Íĸ±íÃæ°üÀ¨Èçϲ½Öè¢ÙÌáÈ¡ËùÊöDNAÎÄ¿âµÄÖÊÁ£×ª»¯ËùÊö½Íĸ£¬µÃµ½ÖØ×é½Íĸ£»¢ÚÊÕ¼¯ÖØ×é½ÍĸÓÕµ¼ÅàÑø36СʱÒÔÉÏ£¬µÃµ½½ÍĸչʾÎĿ⣻ËùÊöÓÕµ¼ÊÇͨ¹ýÏòÅàÑø ½ÍĸµÄÌåϵÖмÓÈë°ëÈéÌÇʵÏֵġ£
5.ÈçȨÀûÒªÇó1ÖÁ4ÖÐÈÎÒ»ËùÊöµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚ²½Öè(1)ÖУ¬¹¹½¨ËùÊöDNA ÎÄ¿âµÄ·½·¨°üÀ¨Èçϲ½Öè(1)½«Ä¿µÄµ°°×µÄ±àÂë»ùÒòÓÃDNaseI½øÐÐÏû»¯£¬»ØÊÕ50_100bpµÄDNAƬ¶Î£»(2)½«²½Öè(1)»ØÊÕµÄDNAƬ¶Î½øÐÐËæ»úƬ¶ÎÖØ×飻(3)½«²½Öè(2)ÖØ×éºóµÄDNAƬ¶Î¼ÓAβ£»(4)½«¼ÓAβºóµÄDNAƬ¶Î²åÈëËùÊöpCTCON2-TÖÊÁ£µÄXcmIøÇÐλµã£¬È»ºóת »¯ËÞÖ÷¾ú£¬µÃµ½ËùÊöDNAÎĿ⡣
6.ÈçȨÀûÒªÇó5ËùÊöµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚËùÊöËÞÖ÷¾úΪ´ó³¦¸Ë¾ú£¬ÓÅÑ¡´ó³¦¸Ë¾ú DH5a¡£
7.ÈçȨÀûÒªÇó1ÖÁ6ÖÐÈÎÒ»ËùÊöµÄ·½·¨£¬ÆäÌØÕ÷ÔÚÓÚËùÊöÄ¿µÄµ°°×ΪÐòÁбíµÄÐòÁÐ 1ËùʾµÄµ°°×£»ËùÊöÄ¿µÄµ°°×µÄ±àÂë»ùÒòÓÅÑ¡ÐòÁбíµÄÐòÁÐ2ËùʾµÄDNA¡£
8.pCTCON2-TÖÊÁ££¬ÊÇÔÚpCTCON2ÖÊÁ£µÄNheIºÍBamH IλµãÖ®¼ä²åÈëÐòÁбíµÄ ÐòÁбí3×Ô5¡¯Ä©¶ËµÚ11ÖÁ40λºËÜÕËáËùʾµÄDNAµÃµ½µÄ¡£
9.Ò»ÖÖ½Íĸ±íÃæÕ¹Ê¾ÏµÍ³£¬°üÀ¨È¨ÀûÒªÇó8ËùÊöµÄpCTCON2-TÖÊÁ£ºÍ½Íĸ¡£
10.ÈçȨÀûÒªÇó9ËùÊöµÄ½Íĸ±íÃæÕ¹Ê¾ÏµÍ³£¬ÆäÌØÕ÷ÔÚÓÚËùÊö½ÍĸΪÄð¾Æ½Íĸ£¬ÓŠѡΪÄð¾Æ½ÍĸEBY100¡£
È«ÎÄÕªÒª
±¾·¢Ã÷¹«¿ªÁËÒ»ÖÖ·ÖÎöµ°°×µÄ¿¹Ô±íλµÄ·½·¨¡£±¾·¢Ã÷µÄ·½·¨°üÀ¨Èçϲ½Öè(1)¹¹½¨Ä¿µÄµ°°×µÄDNAÎĿ⣻µ°°×µÄ±àÂë»ùÒòµÄDNAƬ¶Î²åÈëTÔØÌ壻TÔØÌ庬½ÍĸaÄý¼¯ËØAga2pµÄ±àÂë»ùÒò£¬DNAƬ¶Î±àÂëµÄëĶÎÓë½ÍĸaÄý¼¯ËØAga2pµÄC¶ËÈںϣ»(2)½«DNAÎÄ¿âչʾÔÚ½Íĸ±íÃæ£¬µÃµ½½ÍĸչʾÎĿ⣻(3)·ÖÑ¡³öÓëÄ¿µÄµ°°×µÄ¿¹Ìå½áºÏµÄ½Íĸ£»(4)ÌáÈ¡ÖÊÁ£²âÐò£¬·ÖÎöµ°°×µÄ¿¹Ô±íλ¡£±¾·¢Ã÷¾ßÈçÏÂÓŵã(1)½Íĸϸ°û¶Ôµ°°×µÄÐÞÊÎ;¾¶¶à£¬¿É·½±ãµØÕ¹Ê¾´ó·Ö×ÓÁ¿ºÍ¸´Ôӵĵ°°×£¬¸üºÃµÄÄ£Äâ¿Õ¼ä¹¹Ïó£»(2)½Íĸ¿É²ÉÓÃFACSÖð¸öɸѡ£¬Ìá¸ß׼ȷÐÔÓëɸѡͨÁ¿£»(3)½Íĸ¿É¶ÀÁ¢Íê³É×ÔÉíµÄÉú³¤¸´Öƹý³Ì£¬²Ù×÷¼ò±ã£¬¸ÉÈÅÒòËØÉÙ£»(4)½Íĸ²»Ò×±»¿ÕÆø´«²¥£¬²»Ò×½»²æ¸ÐȾ¡£
Îĵµ±àºÅG01N33/569GK102021242SQ201010526018
¹«¿ªÈÕ2011Äê4ÔÂ20ÈÕ ÉêÇëÈÕÆÚ2010Äê10ÔÂ25ÈÕ ÓÅÏÈȨÈÕ2010Äê10ÔÂ25ÈÕ
·¢Ã÷ÕßÁõÖлª, Ê·ÐûÁá, ×óÌÚ, ÕÅÁÖçù, ÐìÍûêÍ, ÁÖÕÂÁÝ ÉêÇëÈË:Ç廪´óѧ